Therefore, in obese cirrhotic patients without features of sarcopenic obesity, dietary interventions such as intermittent fasting can reduce hepatic and systemic inflammation and insulin resistance, re-balance the levels of adipokines and reduce the risk of liver decompensation, finally decreasing the risk of HCC development. Here, INS is linked to hepatocellular carcinoma.